Intramural hematoma of aortic coarctation requires different treatment options according to the different characteristics of the extent of hematoma involvement, including surgical treatment and drug treatment. 1. Surgical treatment: Type A intramural hematoma involving the ascending aorta is very dangerous and can lead to aneurysm formation or rupture, so surgical treatment should be actively considered to reduce the mortality rate of such patients; Type B intramural hematoma with penetrating aortic ulcer should be treated with endoluminal stenting if the patient has pain, uncontrollable blood pressure, progressive increase of pleural effusion, and rapid increase of intramural hematoma thickness. 2. Pharmacological treatment: Except for patients with low blood pressure, all patients should be injected with antihypertensive drugs as soon as they are diagnosed with aortic coarctation intramural hematoma. The current standard of care is a combination of beta-blockers (e.g., metoprolol) and vasodilators (e.g., sodium nitroprusside). Type B intramural hematomas of the aorta that do not involve the ascending aorta and are not associated with aortic penetrating ulcers are well treated medically. Intramural hematomas of aortic coarctation have a relatively good prognosis compared to extensive coarctation formation, and patients are advised to actively cooperate with their medical professionals.